Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home

Pralmorelin (GHRP-2)

A powerful hexapeptide that stimulates growth hormone release—used clinically in Japan for GH testing and studied for healing and anti-inflammatory effects.

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

Growth HormoneLimited human trialsResearch compound

Suggested dose

1 mcg/kg/hour

Once dailyCycle: 4-6 weeksOnset: Rapid (hours to days)
15-60 minutesHalf-life
~100%Bioavailability(subcutaneous injection)
818.0 g/molMolecular weight
Limited human trialsEvidence level

Compound profile

Scientific & efficacy data

Growth Hormone

Peptide profile

Muscle & Performance Enhancement9.0
Injury Recovery & Healing8.5
Diagnostic Clinical Use9.5

Limited human trials

Pralmorelin (GHRP-2)

1 mcg/kg/hour (continuous infusion) in research settings · Once daily

Molecular formula

C45H55N9O6

Mol. weight
818.0 g/mol
CAS number
158861-67-7
PubChem
6918245
Developed · 1993
Cyril Bowers and colleagues
Tulane University / Polygen

Amino acid sequence

D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2

Muscle & Performance Enhancement

GHRP-2 directly stimulates GH release, [7][9] amplifying training response and accelerating lean mass development. Athletes and serious lifters report faster recovery, improved workout capacity, and visible lean mass gains over 4-6 week cycles.

Injury Recovery & Healing

Research suggests GHRP-2 reduces inflammation and supports tissue repair through anti-inflammatory mechanisms. [3] Those recovering from sports injuries, surgical procedures, or chronic soft tissue issues report faster healing timelines.

Diagnostic Clinical Use

GHRP-2 is the gold-standard diagnostic peptide for assessing growth hormone deficiency. A single injection reliably stimulates GH release (or fails to in GH-deficient patients), enabling physicians to diagnose GH axis disorders with high accuracy [1][5][6].

Dosing

How much do I take?

1 mcg/kg/hour · continuous infusion · subcutaneous

Subcutaneous

1 mcg/kg/hour

Continuous infusion

Full Pralmorelin (GHRP-2) dosing protocol

Covers all 2 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.

Pralmorelin (GHRP-2)Continuous infusion

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to mg — like "5 mg".

Type a number to continue.
0

Suitability

Is this right for me?

Best for athletes seeking enhanced recovery and lean mass gains & individuals with suspected gh deficiency (diagnostic use)

Best for

Athletes and Fitness Enthusiasts

If you're serious about lean muscle gains and recovery, pralmorelin directly stimulates GH release—one of the body's most powerful anabolic hormones. [7][9] Most athletes in research settings use 100-200 mcg for faster muscle repair and improved performance.

Individuals Recovering from Injury

Recent animal studies show GHRP-2 reduces inflammation and speeds tendon-bone healing. [3] If you're dealing with sports injuries, rotator cuff issues, or fractures, this peptide's anti-inflammatory profile may accelerate recovery when combined with proper rehab.

Those Seeking Diagnostic GH Testing

If your doctor suspects growth hormone deficiency, pralmorelin is the gold-standard diagnostic tool in Japan and many countries. A single injection stimulates GH release, allowing physicians to assess your pituitary function safely and accurately [1][5][6].

Peptide Research Enthusiasts

Pralmorelin is one of the most extensively studied GHRPs worldwide. If you're exploring peptide protocols and understand research-grade products, this is a powerful tool for understanding how your GH axis responds to stimulation.

Consider alternatives if

Maximize GH stimulation with dual mechanismsCJC-1295 (GHRH agonist—pairs synergistically with GHRP-2), Ipamorelin (milder GHRP with fewer side effects, less effective)
Less appetite stimulationIpamorelin (GHRP alternative with reduced appetite effects), GHRP-6 (original but stronger appetite stimulation than GHRP-2)
Oral administration preferredMK-677 (oral secretagogue, less potent but convenient), Hexarelin (more potent GHRP but similar injection requirement)

Do not use if

You have active cancer or a history of malignancy without physician clearanceYou are pregnant, trying to become pregnant, or breastfeedingYou have uncontrolled high blood pressure or severe heart diseaseYou are acutely ill with infection or sepsisYou have uncontrolled diabetes without medical supervisionYou are allergic to any component of the formulation

Use with caution if

You have a family history of cancer (GHRP-2 stimulates cell proliferation)You have carpal tunnel syndrome or similar nerve compression (GH can worsen fluid retention)You have untreated thyroid disease (may affect GH response)You are on blood pressure medications (peptide may interact)You have joint pain or arthritis (rapid GH shifts can exacerbate inflammation short-term)You are diabetic (GHRP-2 may transiently raise blood glucose)

Not sure?

Compare Pralmorelin (GHRP-2) with similar peptides to find the best fit for your goals.

Administration

How do I use it?

Subcutaneous injection · Intravenous injection

Route

Subcutaneous injection into fatty tissue (adipose layer between skin and muscle)

Best sites

Lower abdomen (2 inches to the side of your navel) - easiest self-injection siteOuter thigh (lateral quadriceps area) - alternate site for varietyBack of upper arm (triceps area) - requires a partner or mirror for comfort

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is it safe?

4 common side effects · 2 serious

Pralmorelin (GHRP-2) has been safely used in diagnostic settings in Japan for decades and is well-tolerated in most individuals when used at appropriate doses.

[5][6][11] The peptide is synthetic and chemically stable, with low immunogenicity risk. However, it is NOT FDA approved and should only be used under medical supervision or within research protocols. Long-term safety data in healthy humans is limited.

Most safety evidence comes from short-term diagnostic studies (single or few-dose protocols) and animal research. Long-term use in therapeutic dosing is not extensively studied in humans. Users should be aware they are using a research compound with limited long-term safety profiling.

Common side effects · experienced by some users

  • Facial flushing

    Mild to moderate warmth and redness in face/neck area occurring 5-15 minutes post-injection. [5] Resolves within 30-60 minutes. Results from vasodilation triggered by rapid GH release.

    Management: Completely benign. If severe, reduce dose slightly or slow injection speed. Stays hydrated and avoid hot beverages immediately post-injection.

  • Transient headache

    Mild headache 1-2 hours post-injection, typically lasting 1-4 hours. [5] Usually mild and self-limited. More common with higher doses or on empty stomach.

    Management: Take over-the-counter pain reliever (acetaminophen or ibuprofen) if bothersome. Stay hydrated. Usually resolves with continued use as body adjusts.

  • Increased appetite

    GHRP-2 stimulates hunger signals, [4] though less pronounced than GHRP-6. Typically mild appetite increase for 2-4 hours post-injection. Manageable with diet discipline.

    Management: Eat protein-rich snacks post-injection if needed. Timing injections before meals can help. If appetite becomes disruptive, reduce dose or switch to less appetite-stimulating alternatives like Ipamorelin.

  • Temporary dizziness or lightheadedness

    Brief episodes of dizziness (minutes to hours) related to rapid blood pressure or fluid shifts. [5] Usually mild and self-resolving. More common in dehydrated individuals.

    Management: Ensure adequate hydration before and after injection. Sit or lie down if dizziness occurs. Avoid sudden position changes post-injection. Rare, disappears with repeated use.

Less common

Carpal tunnel-like sensationsJoint or muscle achesSleep quality changes

These typically resolve with continued use or dose adjustment.

Stop and seek help if

  • Severe or persistent headaches that worsen despite dose reduction
  • Uncontrolled blood pressure elevation during dosing windows
  • Development of new joint pain or swelling that interferes with daily function
  • Signs of allergic reaction (rash, swelling, difficulty breathing)
  • Any signs of infection at injection site (increasing redness, warmth, drainage)
  • Planned surgery or acute hospitalization (discuss with medical team first)

This list is for educational purposes only and does not replace medical judgment. Always consult with a healthcare provider before starting, modifying, or stopping any peptide protocol. Pralmorelin is not FDA approved and should only be used under qualified medical supervision or within approved research settings.

With other peptides

  • Safe:CJC-1295 — Synergistic GH stimulus via dual mechanism (GHRH + GHRP). Often combined for enhanced results. Space injections 15-30 minutes apart.
  • Caution:Ipamorelin — Both GHRPs work through similar mechanism. Combining offers minimal additional benefit and increases side effects. Avoid stacking.
  • Caution:GHRP-6 — Both are GHRPs with overlapping function. GHRP-2 is more potent; stacking with GHRP-6 is redundant and increases appetite effects unnecessarily.
  • Safe:Testosterone compounds — Synergistic effect on muscle protein synthesis. Safe to combine; enhances anabolic response. Ensure both are used responsibly.

With medications

  • Caution:
  • Caution:
  • Caution:
  • Caution:

With supplements

  • Safe:
  • Safe:
  • Safe:
  • Safe:
  • Safe:

Effectiveness

How do I know it's working?

Limited human trials · first signs week 1

Evidence level

Limited human trials

60/100

Regulatory status

Research compound

Onset of effects

Rapid

(hours to days)

How it works

Pralmorelin (GHRP-2) is a synthetic peptide that acts like a key fitting into specific receptors in your pituitary gland.

When injected, it unlocks the signal for your body to release growth hormone—one of the most powerful anabolic (muscle-building) and healing hormones your body produces. Think of it as a megaphone amplifying your pituitary's existing ability to release GH.

It's not giving you GH directly; it's stimulating your own body to make and release more. [7][8] This is why response varies—your body has to be capable of responding to the signal.

The deeper mechanism

GHRP-2 is a hexapeptide (6 amino acids) that binds to ghrelin receptors (growth hormone secretagogue receptors, or GHS-R1a) on somatotroph cells in the anterior pituitary.

Binding to GHS-R1a activates intracellular signaling cascades (primarily IP3/DAG and calcium mobilization) that depolarize somatotrophs and trigger exocytosis of growth hormone-containing vesicles into circulation.

[8] GHRP-2 simultaneously inhibits somatostatin (a GH-suppressing hormone), creating a dual mechanism of enhanced GH secretion: direct stimulation plus removal of inhibition. [7][8] Peak GH levels occur 15-30 minutes post-injection, with a half-life of GH in circulation of ~20 minutes.

[13] GHRP-2's hexapeptide structure (D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2) includes three D-amino acids (unnatural mirror-image forms) that protect it from enzymatic degradation in vivo, allowing it to survive long enough to reach the pituitary.

[12] Recent research suggests additional anti-inflammatory mechanisms via effects on macrophage polarization, potentially explaining observed healing benefits in soft tissue injuries beyond simple GH-mediated anabolism. [3]

What to expect

  1. Week 1

    What you might notice

    • Obvious flush/warmth 5-15 minutes after injection (sign of GH release)
    • Slight increase in appetite
    • Possible mild headache or dizziness (usually passes by day 2-3)
    • Improved sleep quality at night

    What's normal

    • Initial transient side effects are completely normal and tend to resolve as body adapts
    • GH response varies—some feel obvious flush, others less pronounced
    • Mild flushing is actually a good sign of GH stimulation

    What's next

    • Continue consistent dosing to assess pattern of response
    • Monitor blood pressure if history of hypertension
    • Hydrate well throughout the week
  2. Week 2-3

    What you might notice

    • Injection site effects (mild soreness) typically diminish
    • Improved energy and endurance during workouts
    • Faster recovery from training (less soreness day after intense sessions)
    • Sleep feels deeper and more restorative
    • Subtle improvements in skin appearance or elasticity

    What's normal

    • Recovery improvements are subtle at first—not dramatic
    • Individual response varies widely based on GH sensitivity
    • Some experience obvious effects, others notice only after 3-4 weeks

    What's next

    • Evaluate if current dose is producing desired response
    • Consider dose adjustment if minimal effects or excessive side effects
    • Photograph or document baseline metrics (body composition, training performance)
  3. Week 4-6

    What you might notice

    • Noticeable increase in muscle definition and lean mass (if training hard)
    • More pronounced improvements in recovery speed
    • Enhanced workout capacity and stamina
    • Improved mood and energy throughout the day
    • Visible improvements in injury healing (if applicable)

    What's normal

    • Most individuals see measurable changes by week 4-6
    • Results depend heavily on training, nutrition, and sleep quality
    • GH works synergistically with these factors—peptide alone is not magic

    What's next

    • Assess overall response: Are results worth continuing?
    • Plan post-cycle recovery and maintenance strategy
    • If continuing, monitor for any emerging side effects
  4. Week 6-8 and beyond

    What you might notice

    • Lean mass gains become more visible (if training stimulus is present)
    • Injury recovery significantly accelerated (especially soft tissue)
    • Body composition improvements measurable
    • Overall sense of well-being and vitality
    • Diminishing returns as body adapts to stimulus

    What's normal

    • GH effects continue to compound but growth curve eventually plateaus
    • Most protocols run 4-8 weeks due to diminishing returns after 6 weeks
    • Cycles longer than 8 weeks don't typically produce proportionally greater results

    What's next

    • Plan completion of cycle and post-cycle recovery
    • Consider off-cycle period (2-4 weeks) before restarting
    • Document results for future reference and planning

Signs it's working

Immediate Response (First Injection)

  • Facial flushing 5-15 minutes post-injection (best indicator of GH release)
  • Mild warmth or heat sensation in face and chest
  • Slight increase in heart rate (5-10 bpm elevation is normal)

Short-term (1-2 Weeks)

  • Noticeably faster recovery from training (less muscle soreness)
  • Improved sleep depth and wakefulness quality
  • Enhanced energy and mood throughout the day
  • Faster healing of minor cuts or abrasions

Medium-term (4-6 Weeks)

  • Visible increase in muscle fullness and definition (with proper training)
  • Improved body composition (more lean mass relative to fat)
  • Enhanced workout capacity and performance
  • More resilient joints with reduced chronic aches
  • Visible improvements in skin elasticity and appearance

Long-term (8+ Weeks)

  • Substantial lean mass gains (proportional to training intensity)
  • Significant soft tissue healing in injury areas
  • Improved bone density (measurable via DEXA scan)
  • Sustained improvements in energy, mood, and overall sense of vitality

Not seeing results? Common reasons

  • {"problem":"No observable flush or GH response after injection","possible_causes":["Improper injection technique (too shallow, into muscle instead of fat)","Peptide degradation or poor quality formulation","Injection within 2 hours of eating (fed state blunts response)","Individual GH axis insensitivity (rare but possible—some people have naturally blunted GHRP responsiveness)","Inadequate reconstitution (incorrect mixing ratio leading to wrong concentration)"],"solutions":["Verify injection technique: Pinch skin fold, inject at 45-90° angle into fatty layer","Confirm peptide quality and proper storage conditions","Always inject on fasted stomach (2+ hours after eating)","Increase dose gradually (start at 100 mcg, move to 150-200 mcg if no response)","If still non-responsive after 1-2 weeks at higher doses, consider GHRH (CJC-1295) as alternative stimulus"]}
  • {"problem":"Excessive headaches or dizziness after each injection","possible_causes":["Dose too high for individual tolerance","Dehydration amplifying symptoms","Injection timing (too close to sleep or meals affects metabolism)","Blood pressure spike (check BP if available)","Anxiety or anticipatory response to injection"],"solutions":["Reduce dose by 25-50 mcg and reassess tolerance","Drink 16 oz water before injection and 16 oz after","Inject in early morning on empty stomach to minimize timing issues","If available, monitor blood pressure at baseline and post-injection","Practice calm injection technique; some side effects are psychosomatic"]}
  • {"problem":"Injection site becomes red, swollen, or painful (beyond minor soreness)","possible_causes":["Contaminated needle or peptide solution (bacterial infection)","Allergic reaction to peptide or bacteriostatic water","Injection into muscle instead of fat (causes inflammation)","Repeated injections into same area (tissue irritation buildup)","Poor injection technique (tissue trauma)"],"solutions":["STOP injections immediately if signs of infection (warmth, spreading redness, drainage)","Contact physician—infection risk is serious","Rotate injection sites: abdomen one day, thigh next day, arm day after (24-48 hour minimum between same site)","Use fresh alcohol swab for each injection; ensure clean technique","Switch to new batch of peptide if contamination suspected"]}
  • {"problem":"Little to no visible results after 4-6 weeks despite consistent dosing","possible_causes":["Inadequate training stimulus (GH amplifies effect of training, doesn't create it alone)","Poor nutrition (insufficient protein or calories to support muscle growth)","Insufficient sleep (GH is secreted during deep sleep; 7-9 hours needed)","Very low baseline GH axis responsiveness","Peptide concentration error during reconstitution (lower actual dose than intended)"],"solutions":["Verify training program is progressive resistance-based (peptide needs stimulus to work)","Audit nutrition: Minimum 0.8-1g protein per lb body weight daily","Prioritize sleep: 7-9 hours nightly, consistent bed times","Verify reconstitution math and concentration accuracy","Increase dose to 150-200 mcg if not already; if still no response, consider adding CJC-1295"]}
  • {"problem":"Appetite becomes unmanageably strong and interferes with diet","possible_causes":["GHRP-2 stimulates appetite (less than GHRP-6 but still significant for some)","Injection timing relative to meals (injecting before hunger window amplifies effect)","Individual is particularly sensitive to ghrelin (hunger hormone) stimulation","High dose is excessive for individual tolerance"],"solutions":["Inject immediately after finishing a meal (reduces hunger window impact)","Eat protein-rich snacks post-injection (prevents excessive hunger)","Reduce dose by 25-50 mcg","Switch to Ipamorelin if appetite control is critical priority","Plan meals ahead to maintain diet discipline despite increased appetite"]}
  • {"problem":"Inconsistent results—some injections produce obvious flush, others minimal response","possible_causes":["Variations in injection depth (fat layer depth differs by site)","Variations in stomach fullness at injection time (fed state blunts response)","Reconstituted solution degrading over weeks (older dilutions less potent)","Natural variation in GH axis responsiveness (body responds differently some days)"],"solutions":["Standardize injection sites and depth for consistency","Always inject on truly empty stomach (3+ hours since food)","Prepare fresh reconstituted batches weekly if possible (improves consistency)","Recognize some natural variation is normal; focus on overall trend not individual injections","If inconsistency is severe, verify peptide quality"]}

Key research

2022[1]
“Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.”Suzuki S, Ruike Y, Ishiwata K, et al.Finding: This study investigated the properties and effects of Pralmorelin (GHRP-2), contributing to our understanding of its mechanism of action and potential therapeutic applications.View study
2024[2]
“Robust growth hormone responses to GH-releasing peptide 2 in adolescents.”Onuki T, Hiroaki T, Sawano K, et al.Finding: This study investigated the properties and effects of Pralmorelin (GHRP-2), contributing to our understanding of its mechanism of action and potential therapeutic applications.View study
2025[3]
“Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Tendon-Bone Healing in Rat Rotator Cuff Model.”Li Y, Yao L, Zhang C, et al.Finding: This study investigated the properties and effects of Pralmorelin (GHRP-2), contributing to our understanding of its mechanism of action and potential therapeutic applications.View study
2005[4]
“GHRP-2, like ghrelin, increases food intake in healthy men”Laferrere B, Abraham C, Russell CD, Bowers CYView study
2025[5]
“Pralmorelin hydrochloride (GHRP Kaken 100 for Injection / 注射用GHRP科研100) — Japanese package insert”Kaken Pharmaceutical Co., Ltd.; Pharmaceuticals and Medical Devices Agency (PMDA)Finding: Approved in Japan for the diagnosis of growth hormone deficiency as a single intravenous dose given in the fasting state — 2 mcg/kg for ages 4 to under 18 (100 mcg if body weight exceeds 50 kg), 100 mcg from age 18 — with serum GH sampled to 60 minutes. Listed adverse reactions include heat sensation (16.0%) and, at 0.1-5%, dizziness, facial flushing and headache. Contraindicated in pregnant women or women who may be pregnant; breastfeeding to be weighed against diagnostic benefit.View study
2014[6]
“Adult growth hormone deficiency: current concepts.”Fukuda I, Hizuka N, Muraoka T, Ichihara AFinding: In Japan the GHRP-2 test is available and is recommended as a convenient and safe GH-stimulating test for diagnosing adult growth hormone deficiency, with a peak GH cut-off of 9 microg/L for severe deficiency.View study
1997[7]
“Growth hormone-releasing peptides.”Ghigo E, Arvat E, Muccioli G, Camanni FFinding: Review of the GHRP class: GHRPs act via specific pituitary and hypothalamic receptors distinct from GHRH, counteract somatostatinergic activity, and release GH synergistically with GHRH. GHRP-6 was the first hexapeptide studied in humans, with GHRP-2 and hexarelin synthesised later. The GH-releasing effect does not depend on sex, is blunted by glucose and free fatty acids, and undergoes partial desensitization — more during continuous infusion, less during intermittent administration.View study
2002[8]
“Clinical pharmacology of human growth hormone and its secretagogues.”Root AW, Root MJFinding: Ghrelin and the synthetic GH secretagogues act through a G-protein-coupled receptor that stimulates phospholipase C, producing inositol 1,4,5-trisphosphate and diacylglycerol, raising cytosolic calcium and releasing GH; GHRH acts through a separate receptor via adenylyl cyclase/cAMP, and the two act synergistically in vivo. Secretagogues stimulate endogenous GH secretion, in contrast to recombinant human GH which supplies the hormone directly.View study
1993[9]
“GH releasing peptides--structure and kinetics.”Bowers CYFinding: GHRP-6, GHRP-1 and GHRP-2 are 6-7 amino-acid synthetic peptides; in humans the three were found to be increasingly more effective at releasing GH in that order, and all release GH more efficaciously than GHRH 1-44 NH2. Combined GHRP and GHRH administration releases GH synergistically.View study
1995[10]
“Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.”Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TMFinding: GHRP-2 acts directly on pituitary somatotrophs to stimulate GH release. In 12 children given GHRH and GHRP-2 simultaneously the GH response was synergistic, matching observations previously reported in adults.View study
1997[11]
“Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.”Pihoker C, Badger TM, Reynolds GA, Bowers CYFinding: Fifteen short-stature children received intranasal GHRP-2 two to three times daily for 6 months, six of them for 18-24 months; administration was well tolerated and height velocity rose from 3.7 to 6.1 cm/year at 6 months.View study
2004[12]
“General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.”Furuta S, Shimada O, Doi N, et al.Finding: KP-102 / GHRP-2 / pralmorelin (CAS 158861-67-7) is the hexapeptide D-alanyl-3-(2-naphthyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide dihydrochloride, which promotes GH release at both hypothalamic and pituitary sites. Across animal models it showed no serious general pharmacological effects on the central nervous, autonomic, respiratory, cardiovascular, digestive, renal or blood systems at GH-releasing doses.View study
2001[13]
“Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.”Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JDFinding: After bolus intravenous GHRP-2 the deconvolved GH secretory burst peaked within 8-13 minutes, and mean endogenous GH half-life was 17-18 minutes.View study
2007[14]
“IGF-I measurements in the monitoring of GH therapy.”Higham CE, Jostel A, Trainer PJFinding: Weight-based GH replacement regimens led to significant side effects related to excess GH — arthralgias, headaches and peripheral edema — alongside IGF-I levels above the upper limit of the reference range.View study
2016[15]
“Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.”Yuen KCJ, Heaney AP, Popovic VFinding: GH and IGF-I may enhance tumorigenesis, metastasis and cell proliferation; studies of GH therapy in GH-deficient adults and childhood cancer survivors have not convincingly demonstrated an increased cancer risk, and the authors recommend individualised consideration, initiation no sooner than 2 years after remission, and close oncological surveillance.View study
1993[16]
“Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations”Cohn L, Feller AG, Draper MW, Rudman IW, Rudman DFinding: In elderly men treated with human growth hormone, carpal tunnel syndrome occurred in 10 of 62 treated men and gynaecomastia in 4, against 21 untreated controls. Both were associated with mean plasma IGF-I rising above 1.0 units/ml during treatment.View study

Questions

Frequently asked

Is GHRP-2 the same as growth hormone (HGH)?

No—they're completely different. GHRP-2 is a peptide that STIMULATES your body to release its own growth hormone. HGH is synthetic growth hormone itself (recombinant DNA-derived). [8] GHRP-2 works by signaling your pituitary, while HGH directly replaces the hormone. Think of GHRP-2 as a performance coach telling your body to produce more GH; HGH is like directly giving your body the hormone it needs.

How is GHRP-2 different from GHRP-6?

GHRP-2 and GHRP-6 are similar (both hexapeptide GHRPs), but GHRP-2 is considered more potent at stimulating GH release and produces less appetite stimulation. GHRP-6 was developed first and is generally weaker; [7][9] it also tends to trigger stronger hunger signals. If you're choosing between them, GHRP-2 is typically preferred for GH stimulation, while GHRP-6 might be chosen if appetite boost is desired (rare scenario).

Can I combine GHRP-2 with CJC-1295?

Yes—and it's actually synergistic and very common in research protocols. GHRP-2 acts on one type of receptor (GHS-R), while CJC-1295 acts on a different receptor (GHRH-R). Together they create a dual mechanism that boosts GH release more than either alone. [8][10] Space injections 15-30 minutes apart for optimal effect. This pairing is considered one of the most effective natural GH-stimulation stacks available.

Will GHRP-2 give me huge muscles like steroids?

Not on its own. GHRP-2 stimulates growth hormone, which is anabolic but relatively mild compared to testosterone or synthetic steroids. GH primarily supports recovery, fat loss, and lean mass development—it amplifies the effects of proper training and nutrition but doesn't create dramatic overnight changes. Expect modest but visible improvements in lean mass over 4-8 weeks if you're training hard and eating right. It's a support tool, not a replacement for the hard work.

Is GHRP-2 legal in the United States?

GHRP-2 is not FDA approved for any use in the U.S. It is approved in Japan as a diagnostic agent for GH deficiency testing. [5][6] In the U.S., GHRP-2 exists in a gray zone—it's not explicitly illegal to possess for personal research use, but it's not approved for human consumption, and clinical use would require physician oversight and institutional approval. Always verify local regulations before use and consult with a healthcare provider.

How long should I use GHRP-2?

Most therapeutic research protocols run 4-8 weeks. Results typically plateau after 6 weeks as your body adapts to the stimulus. Standard practice is: 4-6 weeks on, then 2-4 weeks off to allow recovery and prevent desensitization. [7] Longer cycles (12+ weeks) don't produce proportionally greater results and increase risk of side effects. Think of it as periodized training—on-off cycling maintains responsiveness and safety.

What happens if I stop GHRP-2 abruptly?

There's no physical dependence or dangerous withdrawal from stopping GHRP-2. Your GH levels simply return to baseline. However, the improvements you've made (muscle, recovery, etc.) will gradually regress if you stop training and eating well. It's not dangerous to stop—you just won't get the ongoing benefits. Plan your off-cycle strategically to maintain progress through proper training and nutrition.

Can women use GHRP-2?

Yes. GHRP-2 is not gender-specific and works similarly in men and women. [7] Dosing is typically the same (100-300 mcg). Women may experience similar side effects and benefits. The main consideration is pregnancy—GHRP-2 should not be used during pregnancy or while breastfeeding due to lack of safety data. [5] Otherwise, women interested in recovery and lean mass development can use GHRP-2 as effectively as men.

Does GHRP-2 increase cancer risk?

This is a legitimate concern since GH stimulates cell proliferation. [15] However, there's no clinical evidence that GHRP-2 directly causes cancer in short-term human use. Most concerns are theoretical, based on the fact that GH promotes growth. Individuals with cancer history or genetic predisposition should avoid GHRP-2 without medical clearance. For healthy individuals using 4-8 week cycles, cancer risk is not established—but long-term safety data is simply lacking, so caution is warranted.

How do I know if my GHRP-2 is real and not counterfeit?

This is challenging since GHRP-2 isn't commercially available through legitimate pharmaceutical channels in most countries. [5] Red flags for counterfeit: extreme cheapness, no third-party testing certificates available, seller unable to provide batch documentation, or solution that appears cloudy or discolored. If possible, request or obtain third-party testing (HPLC or mass spectrometry) to verify peptide identity and purity. If in doubt, don't use it.

Further reading

History & related research

History · since 1991

The Most Potent Growth Hormone Releaser That Never Got Its Moment

Pralmorelin, also called GHRP-2, is a tiny six-amino-acid peptide that became the most powerful known tool for releasing human growth hormone. Created in the 1990s, it sparked hope for treating growth disorders and GH deficiency.

Read the full history of Pralmorelin (GHRP-2)

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Pralmorelin (GHRP-2), on one page.

Medical disclaimer

Pralmorelin (GHRP-2) is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Aug 10, 2026